Cargando…
Decreasing glioma recurrence through adjuvant cancer stem cell inhibition
Gliomas remain one of the most challenging solid organ tumors to treat and are marked clinically by invariable recurrence despite multimodal intervention (surgery, chemotherapy, radiation). This recurrence perhaps, is as a consequence of the failure to eradicate a tumor cell subpopulation, termed ca...
Autores principales: | Neman, Josh, Jandial, Rahul |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2898103/ https://www.ncbi.nlm.nih.gov/pubmed/20631819 |
Ejemplares similares
-
Stem cell-mediated osteogenesis: therapeutic potential for bone tissue engineering
por: Neman, Josh, et al.
Publicado: (2012) -
Inhibition of β2-adrenergic receptor reduces triple-negative breast cancer brain metastases: The potential benefit of perioperative β-blockade
por: CHOY, CECILIA, et al.
Publicado: (2016) -
Stem cells and the origin of gliomas: A historical reappraisal with molecular advancements
por: Levy, Michael L, et al.
Publicado: (2009) -
Cooperation of neurotrophin receptor TrkB and Her2 in breast cancer cells facilitates brain metastases
por: Choy, Cecilia, et al.
Publicado: (2017) -
Altered Expression of Polycomb Group Genes in Glioblastoma Multiforme
por: Li, Gang, et al.
Publicado: (2013)